ClosedBusinessMRFF 2023 TTRA Cardiovascular Disease and Diabetes Mechanisms

MRFF 2023 Targeted Translation Research Accelerator – Cardiovascular Disease and Diabetes Mechanisms Grant Opportunity

Australian Government · Australia

This grant provides funding for medical research projects investigating common pathophysiological mechanisms and disease-related complications focused on cardiovascular disease and diabetes. It supports small scale developmental projects intended to generate knowledge for new diagnostics, devices and therapies.

Funding

Up to $1M

Duration

up to 2 years

Location

Australia

Who Can Apply

Eligible organisations may apply Projects must investigate cardiovascular disease and diabetes mechanisms under the specified topics Only one application per topic may be submitted by an applicant Projects are intended to be early stage, small scale developmental research
Eligible organisations seeking to generate knowledge to support new diagnostics, devices and therapies for people living with cardiovascular disease and diabetes can apply. The opportunity supports Australian medical research and medical innovation projects conducting early stage, small scale developmental research. Applicants can apply for more than one topic with different applications, but can only submit one application per topic. The page also notes that, for each topic, the top 2 ranked applications overall and the next 2 highest ranked applications led by early to mid-career researchers will be funded.

What's Funded

Small scale developmental medical research projects investigating common pathophysiological mechanisms and pathways of disease or disease-related complications in diabetes and cardiovascular disease, including projects under Topic A (any type of diabetes), Topic B (cardiovascular disease and type 1 diabetes), and Topic C (cardiovascular disease and type 2 diabetes).

Expected Outcomes

Generation of knowledge to support new diagnostics, devices and therapies for people living with cardiovascular disease and diabetes, improving the health and wellbeing of Australians.

Key Information

Applicant Types

universityother

Stage

early_stage

Funding Purposes

researchinnovation

Keywords

MRFFMedical Research Future FundTargeted Translation Research Acceleratorcardiovascular diseasediabetesmedical researchdiagnosticsdevices

Frequently Asked Questions

What is the MRFF 2023 Targeted Translation Research Accelerator – Cardiovascular Disease and Diabetes Mechanisms Grant Opportunity?

The MRFF 2023 Targeted Translation Research Accelerator – Cardiovascular Disease and Diabetes Mechanisms Grant Opportunity is a business grant offered by Australian Government in Australia, providing Up to $1M in funding. This grant provides funding for medical research projects investigating common pathophysiological mechanisms and disease-related complications focused on cardiovascular disease and diabetes. It supports small scale developmental projects intended to generate knowledge for new diagnostics, devices and therapies.

How much funding does the MRFF 2023 Targeted Translation Research Accelerator – Cardiovascular Disease and Diabetes Mechanisms Grant Opportunity provide?

The MRFF 2023 Targeted Translation Research Accelerator – Cardiovascular Disease and Diabetes Mechanisms Grant Opportunity provides Up to $1M in funding. The typical project duration is up to 2 years.

Who is eligible for the MRFF 2023 Targeted Translation Research Accelerator – Cardiovascular Disease and Diabetes Mechanisms Grant Opportunity?

Eligible organisations may apply Projects must investigate cardiovascular disease and diabetes mechanisms under the specified topics Only one application per topic may be submitted by an applicant Projects are intended to be early stage, small scale developmental research

What activities are funded?

Small scale developmental medical research projects investigating common pathophysiological mechanisms and pathways of disease or disease-related complications in diabetes and cardiovascular disease, including projects under Topic A (any type of diabetes), Topic B (cardiovascular disease and type 1 diabetes), and Topic C (cardiovascular disease and type 2 diabetes).

How do I apply for the MRFF 2023 Targeted Translation Research Accelerator – Cardiovascular Disease and Diabetes Mechanisms Grant Opportunity?

Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.

Need help applying?

Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.